<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Nasdaq Trade System - Stock Out Like a Sore Thumb</title>
    <!-- Latest compiled and minified CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/css/bootstrap.min.css" rel="stylesheet"
          integrity="sha384-4Q6Gf2aSP4eDXB8Miphtr37CMZZQ5oXLH2yaXMJ2w8e2ZtHTl7GptT4jmndRuHDT" crossorigin="anonymous">
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/js/bootstrap.bundle.min.js"
            integrity="sha384-j1CDi7MgGQ12Z7Qab0qlWQ/Qqz24Gc6BM0thvEMVjHnfYGF0rmFCozFSxQBxwHKO"
            crossorigin="anonymous"></script>
    <meta name="theme-color" content="#712cf9">
</head>

<body>
<header class="navbar sticky-top bg-dark flex-md-nowrap p-0 shadow" data-bs-theme="dark"><a
        class="navbar-brand col-md-3 col-lg-2 me-0 px-3 fs-6 text-white" href="#">Nasdaq Trade system</a>
</header>


<div class="container-fluid">
    <div class="row">
        
        <main class="col-md-9 ms-sm-auto col-lg-10 px-md-4">
            <a href="GameResult.html">Back</a>
            <h1>Stock Out Like a Sore Thumb</h1>
            <img src="Stock Out Like a Sore Thumb.png" class="img-fluid">
            <div class="table-responsive small">
                <table class="table table-striped table-sm">
                    <thead>
                    <tr>
                        <th scope="col">ExecutedOn</th>
                        <th scope="col">Company</th>
                        <th scope="col">Amount</th>
                        <th scope="col">AtPrice</th>
                        <th scope="col">Total</th>
                    </tr>
                    </thead>
                    <tbody>
                    <tr scope="row">
                        <td>03-01-2022</td>
                        <td><a href="stocks/TXMD.html">TherapeuticsMD, Inc. - Common Stock</a></td>
                        <td>51</td>
                        <td>$19.50</td>
                        <td>$994.50</td>
                    </tr>
                    <tr scope="row">
                        <td>04-01-2022</td>
                        <td><a href="stocks/TXMD.html">TherapeuticsMD, Inc. - Common Stock</a></td>
                        <td>-51</td>
                        <td>$22.00</td>
                        <td>-$1,122.00</td>
                    </tr>
                    <tr scope="row">
                        <td>04-01-2022</td>
                        <td><a href="stocks/EBON.html">Ebang International Holdings Inc. - Class A Ordinary Shares</a></td>
                        <td>36</td>
                        <td>$31.20</td>
                        <td>$1,123.20</td>
                    </tr>
                    <tr scope="row">
                        <td>05-01-2022</td>
                        <td><a href="stocks/EBON.html">Ebang International Holdings Inc. - Class A Ordinary Shares</a></td>
                        <td>-36</td>
                        <td>$34.20</td>
                        <td>-$1,231.20</td>
                    </tr>
                    <tr scope="row">
                        <td>05-01-2022</td>
                        <td><a href="stocks/NBTX.html">Nanobiotix S.A. - ADSs</a></td>
                        <td>154</td>
                        <td>$8.00</td>
                        <td>$1,232.00</td>
                    </tr>
                    <tr scope="row">
                        <td>06-01-2022</td>
                        <td><a href="stocks/NBTX.html">Nanobiotix S.A. - ADSs</a></td>
                        <td>-154</td>
                        <td>$9.85</td>
                        <td>-$1,516.90</td>
                    </tr>
                    <tr scope="row">
                        <td>06-01-2022</td>
                        <td><a href="stocks/PHVS.html">Pharvaris N.V. - Ordinary Shares</a></td>
                        <td>91</td>
                        <td>$16.70</td>
                        <td>$1,519.70</td>
                    </tr>
                    <tr scope="row">
                        <td>07-01-2022</td>
                        <td><a href="stocks/PHVS.html">Pharvaris N.V. - Ordinary Shares</a></td>
                        <td>-91</td>
                        <td>$19.30</td>
                        <td>-$1,756.30</td>
                    </tr>
                    <tr scope="row">
                        <td>07-01-2022</td>
                        <td><a href="stocks/BCRX.html">BioCryst Pharmaceuticals, Inc. - Common Stock</a></td>
                        <td>151</td>
                        <td>$11.56</td>
                        <td>$1,745.56</td>
                    </tr>
                    <tr scope="row">
                        <td>10-01-2022</td>
                        <td><a href="stocks/BCRX.html">BioCryst Pharmaceuticals, Inc. - Common Stock</a></td>
                        <td>-151</td>
                        <td>$14.78</td>
                        <td>-$2,231.78</td>
                    </tr>
                    <tr scope="row">
                        <td>10-01-2022</td>
                        <td><a href="stocks/LEE.html">Lee Enterprises, Incorporated - Common Stock</a></td>
                        <td>57</td>
                        <td>$38.87</td>
                        <td>$2,215.59</td>
                    </tr>
                    <tr scope="row">
                        <td>11-01-2022</td>
                        <td><a href="stocks/LEE.html">Lee Enterprises, Incorporated - Common Stock</a></td>
                        <td>-57</td>
                        <td>$43.21</td>
                        <td>-$2,462.97</td>
                    </tr>
                    <tr scope="row">
                        <td>11-01-2022</td>
                        <td><a href="stocks/SWTX.html">SpringWorks Therapeutics, Inc. - common stock</a></td>
                        <td>44</td>
                        <td>$55.40</td>
                        <td>$2,437.60</td>
                    </tr>
                    <tr scope="row">
                        <td>12-01-2022</td>
                        <td><a href="stocks/SWTX.html">SpringWorks Therapeutics, Inc. - common stock</a></td>
                        <td>-44</td>
                        <td>$60.23</td>
                        <td>-$2,650.12</td>
                    </tr>
                    <tr scope="row">
                        <td>12-01-2022</td>
                        <td><a href="stocks/SOPH.html">SOPHiA GENETICS SA - Ordinary Shares</a></td>
                        <td>193</td>
                        <td>$14.00</td>
                        <td>$2,702.00</td>
                    </tr>
                    <tr scope="row">
                        <td>13-01-2022</td>
                        <td><a href="stocks/SOPH.html">SOPHiA GENETICS SA - Ordinary Shares</a></td>
                        <td>-193</td>
                        <td>$15.60</td>
                        <td>-$3,010.80</td>
                    </tr>
                    <tr scope="row">
                        <td>13-01-2022</td>
                        <td><a href="stocks/MLCO.html">Melco Resorts &amp; Entertainment Limited - American Depositary Shares </a></td>
                        <td>316</td>
                        <td>$9.52</td>
                        <td>$3,008.32</td>
                    </tr>
                    <tr scope="row">
                        <td>14-01-2022</td>
                        <td><a href="stocks/MLCO.html">Melco Resorts &amp; Entertainment Limited - American Depositary Shares </a></td>
                        <td>-316</td>
                        <td>$11.10</td>
                        <td>-$3,507.60</td>
                    </tr>
                    <tr scope="row">
                        <td>14-01-2022</td>
                        <td><a href="stocks/PHVS.html">Pharvaris N.V. - Ordinary Shares</a></td>
                        <td>195</td>
                        <td>$17.98</td>
                        <td>$3,506.10</td>
                    </tr>
                    <tr scope="row">
                        <td>18-01-2022</td>
                        <td><a href="stocks/PHVS.html">Pharvaris N.V. - Ordinary Shares</a></td>
                        <td>-195</td>
                        <td>$19.65</td>
                        <td>-$3,831.75</td>
                    </tr>
                    </tbody>
                </table>
            </div>
        </main>
    </div>
</div>
</body>
</html>